drugset / Trial / NCT02492438
13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients
Non-randomizedParallel-groupOpen-labelPrevention
Summary
To assess the immunogenicity of the PCV13 (13 valent pneumococcal conjugated vaccine) vaccine as compared to the PPV23 (23 valent pneumococcal polysaccharide vaccine) vaccine in patients treated with chronic hemodialysis that are pre-immunized with the PPSV23 vaccine or are PPV23 vaccine naïve by measuring the ELISA and OPA (opsonophagocytic assay) titers after 4 and 52 weeks.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-02
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pneumovax 23 | Vaccine | — | — |
| Subject | Prevnar 13 | Vaccine | — | — |